Literature DB >> 33431495

Demographic risk factors for COVID-19 infection, severity, ICU admission and death: a meta-analysis of 59 studies.

Bart G Pijls1, Shahab Jolani2, Anique Atherley3, Raissa T Derckx4, Janna I R Dijkstra5, Gregor H L Franssen6, Stevie Hendriks7, Anke Richters8, Annemarie Venemans-Jellema9, Saurabh Zalpuri10, Maurice P Zeegers11.   

Abstract

OBJECTIVE: We aimed to describe the associations of age and sex with the risk of COVID-19 in different severity stages ranging from infection to death.
DESIGN: Systematic review and meta-analysis. DATA SOURCES: PubMed and Embase through 4 May 2020. STUDY SELECTION: We considered cohort and case-control studies that evaluated differences in age and sex on the risk of COVID-19 infection, disease severity, intensive care unit (ICU) admission and death. DATA EXTRACTION AND SYNTHESIS: We screened and included studies using standardised electronic data extraction forms and we pooled data from published studies and data acquired by contacting authors using random effects meta-analysis. We assessed the risk of bias using the Newcastle-Ottawa Scale.
RESULTS: We screened 11.550 titles and included 59 studies comprising 36.470 patients in the analyses. The methodological quality of the included papers was high (8.2 out of 9). Men had a higher risk for infection with COVID-19 than women (relative risk (RR) 1.08, 95% CI 1.03 to 1.12). When infected, they also had a higher risk for severe COVID-19 disease (RR 1.18, 95% CI 1.10 to 1.27), a higher need for intensive care (RR 1.38, 95% CI 1.09 to 1.74) and a higher risk of death (RR 1.50, 95% CI 1.18 to 1.91). The analyses also showed that patients aged 70 years and above have a higher infection risk (RR 1.65, 95% CI 1.50 to 1.81), a higher risk for severe COVID-19 disease (RR 2.05, 95% CI 1.27 to 3.32), a higher need for intensive care (RR 2.70, 95% CI 1.59 to 4.60) and a higher risk of death once infected (RR 3.61, 95% CI 2.70 to 4.84) compared with patients younger than 70 years.
CONCLUSIONS: Meta-analyses on 59 studies comprising 36.470 patients showed that men and patients aged 70 and above have a higher risk for COVID-19 infection, severe disease, ICU admission and death. PROSPERO REGISTRATION NUMBER: CRD42020180085. © Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.

Entities:  

Keywords:  COVID-19; epidemiology; infectious diseases

Year:  2021        PMID: 33431495     DOI: 10.1136/bmjopen-2020-044640

Source DB:  PubMed          Journal:  BMJ Open        ISSN: 2044-6055            Impact factor:   2.692


  92 in total

1.  Predicting the Disease Severity of Virus Infection.

Authors:  Xin Qi; Li Shen; Jiajia Chen; Manhong Shi; Bairong Shen
Journal:  Adv Exp Med Biol       Date:  2022       Impact factor: 2.622

2.  SARS-CoV-2 antibodies protect against reinfection for at least 6 months in a multicentre seroepidemiological workplace cohort.

Authors:  Emilie Finch; Rachel Lowe; Stephanie Fischinger; Michael de St Aubin; Sameed M Siddiqui; Diana Dayal; Michael A Loesche; Justin Rhee; Samuel Beger; Yiyuan Hu; Matthew J Gluck; Benjamin Mormann; Mohammad A Hasdianda; Elon R Musk; Galit Alter; Anil S Menon; Eric J Nilles; Adam J Kucharski
Journal:  PLoS Biol       Date:  2022-02-10       Impact factor: 8.029

3.  Assessment of Risk Factors Associated with COVID-19 Illness Outcomes in a Tertiary Hospital in Saudi Arabia.

Authors:  Mohammad Aljabr; Areej Aldossary; Kanan Alkanani; Turky Al Zahrani; Sofian Al Mulhim; Hatim Kheir; Assim AlAbdulkader; Hayat Mushcab; Yaser Alreshidi; Nouf Albalawi; Wedyan Alabdullatif; Abrar Almarzooq; Saeed Qahtani; Jaffar A Al-Tawfiq
Journal:  Int J Gen Med       Date:  2022-06-27

4.  Coronavirus disease 2019 in Saudi Arabia: A nationwide real-world characterization study.

Authors:  Khalidah A Alenzi; Wafi F Albalawi; Tahani S Alanazi; Najah S Alanazi; Deemah S Alsuhaibani; Nouf Almuwallad; Thamir M Alshammari
Journal:  Saudi Pharm J       Date:  2022-02-25       Impact factor: 4.562

Review 5.  Is the Endothelium the Missing Link in the Pathophysiology and Treatment of COVID-19 Complications?

Authors:  Pedro Castro; Marta Palomo; Ana Belen Moreno-Castaño; Sara Fernández; Sergi Torramadé-Moix; Georgina Pascual; Julia Martinez-Sanchez; Edward Richardson; Adrián Téllez; Josep M Nicolas; Enric Carreras; Paul G Richardson; Juan José Badimon; Gines Escolar; Maribel Diaz-Ricart
Journal:  Cardiovasc Drugs Ther       Date:  2021-06-07       Impact factor: 3.947

6.  COVID-19 Risk Factors for Cancer Patients: A First Report with Comparator Data from COVID-19 Negative Cancer Patients.

Authors:  Beth Russell; Charlotte L Moss; Kieran Palmer; Rushan Sylva; Andrea D'Souza; Harriet Wylie; Anna Haire; Fidelma Cahill; Renee Steel; Angela Hoyes; Isabelle Wilson; Alyson Macneil; Belul Shifa; Maria J Monroy-Iglesias; Sophie Papa; Sheeba Irshad; Paul Ross; James Spicer; Shahram Kordasti; Danielle Crawley; Kamarul Zaki; Ailsa Sita-Lumsden; Debra Josephs; Deborah Enting; Angela Swampillai; Elinor Sawyer; Paul Fields; David Wrench; Anne Rigg; Richard Sullivan; Mieke Van Hemelrijck; Saoirse Dolly
Journal:  Cancers (Basel)       Date:  2021-05-19       Impact factor: 6.639

7.  Remdesivir, Renal Function and Short-Term Clinical Outcomes in Elderly COVID-19 Pneumonia Patients: A Single-Centre Study.

Authors:  Edoardo Biancalana; Martina Chiriacò; Paolo Sciarrone; Alessandro Mengozzi; Sandra Mechelli; Stefano Taddei; Anna Solini
Journal:  Clin Interv Aging       Date:  2021-06-03       Impact factor: 4.458

8.  Risk factors for adverse outcomes during mechanical ventilation of 1152 COVID-19 patients: a multicenter machine learning study with highly granular data from the Dutch Data Warehouse.

Authors:  Lucas M Fleuren; Michele Tonutti; Daan P de Bruin; Robbert C A Lalisang; Tariq A Dam; Diederik Gommers; Olaf L Cremer; Rob J Bosman; Sebastiaan J J Vonk; Mattia Fornasa; Tomas Machado; Nardo J M van der Meer; Sander Rigter; Evert-Jan Wils; Tim Frenzel; Dave A Dongelmans; Remko de Jong; Marco Peters; Marlijn J A Kamps; Dharmanand Ramnarain; Ralph Nowitzky; Fleur G C A Nooteboom; Wouter de Ruijter; Louise C Urlings-Strop; Ellen G M Smit; D Jannet Mehagnoul-Schipper; Tom Dormans; Cornelis P C de Jager; Stefaan H A Hendriks; Evelien Oostdijk; Auke C Reidinga; Barbara Festen-Spanjer; Gert Brunnekreef; Alexander D Cornet; Walter van den Tempel; Age D Boelens; Peter Koetsier; Judith Lens; Sefanja Achterberg; Harald J Faber; A Karakus; Menno Beukema; Robert Entjes; Paul de Jong; Taco Houwert; Hidde Hovenkamp; Roberto Noorduijn Londono; Davide Quintarelli; Martijn G Scholtemeijer; Aletta A de Beer; Giovanni Cinà; Martijn Beudel; Nicolet F de Keizer; Mark Hoogendoorn; Armand R J Girbes; Willem E Herter; Paul W G Elbers; Patrick J Thoral
Journal:  Intensive Care Med Exp       Date:  2021-06-28

9.  B-Type Natriuretic Peptide Concentrations, COVID-19 Severity, and Mortality: A Systematic Review and Meta-Analysis With Meta-Regression.

Authors:  Angelo Zinellu; Salvatore Sotgia; Ciriaco Carru; Arduino A Mangoni
Journal:  Front Cardiovasc Med       Date:  2021-06-24

Review 10.  Serum CK-MB, COVID-19 severity and mortality: An updated systematic review and meta-analysis with meta-regression.

Authors:  Angelo Zinellu; Salvatore Sotgia; Alessandro G Fois; Arduino A Mangoni
Journal:  Adv Med Sci       Date:  2021-07-07       Impact factor: 3.287

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.